Citius Pharmaceuticals, Inc. Write off of Deferred Debt Issuance Cost
Citius Pharmaceuticals, Inc. (CTXR) reported Write off of Deferred Debt Issuance Cost of $5.40 thousand for the 12-month period ending 2016-09-30, per its 10-K filed 2016-12-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2017-08-14
- Citius Pharmaceuticals, Inc. write off of deferred debt issuance cost for the quarter ending 2016-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. write off of deferred debt issuance cost for fiscal 2016 was $5.40K.
| Period end | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 9 month | Write off of Deferred Debt Issuance Cost 12 month |
|---|---|---|---|
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $5.40K 10-K · filed 2016-12-23 | |
| 2016-06-30 | $5.40K 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |